 In an expansion of its significant global patent estate, Microbot Medical Inc. MBOT announced that the U.S. Patent and Trademark Office USPTO has issued a Notice of Allowance for patent application No. 15218,025, covering the Companys TipCATTM technology platform. The allowed patent application is a Continuation of Patent No. 9,427,143, issued on August 30, 2016. This Notice of Allowance represents a further execution of our overall strategy to create value by protecting our assets and expanding our global IP portfolio to differentiate our unique products and create barriers to entry, said Harel Gadot, Chief Executive Officer, President, and Chairman. 